News

January 25, 2012

FDA APPROVES PICATO® (ingenol mebutate) GEL, THE FIRST AND ONLY TOPICAL ACTINIC KERATOSIS (AK) THERAPY WITH 2 OR 3 CONSECUTIVE DAYS OF ONCE-DAILY DOSING 

 

January 11, 2012

LEO Pharma Inc. Debuts LEO® Quality Care Program for Plaque Psoriasis Patients 

 

January 9, 2012

LEO Pharma A/S in-licenses compound from Virobay Inc. for development of investigational oral treatment of psoriasis

 

December 22, 2011

LEO Pharma Inc. Expands US Presence, Adds Jobs

 

October 11, 2011

LEO Pharma Inc. Hosts TRH the Crown Prince and Crown Princess at U.S./Danish "Building Bridges"/Skin Cancer Awareness Event

 

July 15, 2011

LEO Pharma A/S and The Scripps Research Institute Enter Collaboration

 

April 27, 2011

LEO Pharma Inc. Launches Enhanced Website for Taclonex® Plaque Psoriasis Treatments

 

February 10, 2011

LEO Pharma Inc. Voluntarily Recalls innohep® (tinzaparin sodium injection) Multidose Vials